Drugs from the blood of Ebola patients survive the black market

The product is advertised from the blood of Ebola survivors traded in the West African black market, while the epidemic has not shown signs of cooling down.

The World Health Organization (WHO) is committed to working with host countries to eliminate this illegal trade.

According to WHO, products from infected Ebola blood can contain antibodies against this dangerous virus. However, WHO has not yet conducted a study on which scale to validate its effectiveness. This organization also voiced a warning about potential hazards when this product was illegally traded on the black market.

The blood of surviving Ebola patients is thought to contain natural antibodies against this dangerous virus.(Photo: theguardian.com)

"The risk of other infectious diseases is potential and may not be properly processed according to the procedure," said Margaret Chan, WHO director .

Currently there are no Ebola drugs officially recognized even though many methods are in the testing and development stage. Ebola patients are receiving intravenous fluids, blood transfusions, antibiotics to boost immunity and fight other infectious diseases.

Theoretically, the blood of an infected survivor is capable of producing antibodies that kill the Ebola virus. The inclusion of these special antibodies in the patients' blood will help them strengthen their immune system.

WHO is building a system where safety standards for disease survivors can give blood and study anomalous treatment by using this blood to pass on to people with Ebola. About half of the people infected with Ebola in the current outbreak will recover as a major source of serum treatment.

WHO's judgment, the rapid increase in new infections in West Africa has outstripped the control of local authorities. More than 2,400 people have died out of more than 4,700 cases of infection that turned this outbreak into the biggest and worst Ebola epidemic in history.